. Mutant and WT D2HGDH are co-expressed in DLBCL. Sequencing tracing of RT-PCR products representing the expression levels of three DLCBL-associated D2HGDH mutations indicate that the mutant and WT alleles are equally expressed. The frame-shift nature of the G131X prevented a clear display of the histogram for that variant. However, cloning and sequencing of those RT-PCR products showed a balanced representation of WT and mutant forms (4 mutant, 6 WT in 10 clonesdata not shown). No mRNA was available from tumours harbouring the R212W mutation. The expression of A426T mutation is shown in both a cell line and in a primary DLBCL. A208T A426T; #6902 R421H Reference sequence Mutant sequence A426T; OCI-Ly7 Supplementary Figure 2. D2HGDH is a self-interacting protein. a) FLAG-or HA-tagged D2HGDH WT and mutant constructs were co-transfected in HEK-293 cells (different combinations of WT and mutant proteins are listed on the top). Immunoprecipation (IP) of D2HGDH-FLAG pulled-down HA-D2HGDH (left panel -top). Likewise, IP of HA-D2HGDH, brought-down D2HGDH-FLAG (middle panel -top)
from HEK-293 cells stably expressing WT or mutant D2HGDH constructs. In a) and b) we show that expression of WT D2HGDH led to a decrease in D2-HG when compared to cells expressing the G131X, R208T, and R212W mutants (but not R421H or A426T) (in a, p<0.0001, in b, p=0.0002, ANOVA; in both p<0.05 Bonferroni's Multiple Comparison post-test). Data in a and b represent two biologically independent assays, performed with five and three replicates/sample type, respectively. In c), we show that expression of D2HGDH (WT or mutant) does not alter the levels of L2-HG -assay performed with three replicates/sample type. In d), e) and f), we show that expression of D2HGDH-WT result in a significant accumulation of α-KG when compared to cells expressing an empty or any of the DLBCL-associated mutants (in c and d, p< 0.0001, in e p=0.0112, ANOVA; in all three assays p<0.05 Bonferroni's Multiple Comparison post-test). Data in d, e and f, represent three biologically independent assays, performed with four or five replicates/sample type. The data from panel a) and d) are shown in Figure 1a , depicting the relative abundance of D2-HG and α-KG in models of stable D2HGDH expression. Western blot (bottom) confirms the similar expression of WT and mutant D2HGDHthe antibody used is directed to the C-terminus region and would not detect the G131X truncated protein, which is likely to be unstable (see supplementary Figure 3 ). Metabolites quantifications were normalized by protein amount (mg). Western blot examination confirmed the subtle increase in D2HGDH expression in this model, which resulted in a progressive, significant, decrease in D2-HG levels (left panels in a) and b), p=0.0002 and p=0.0003, respectively -ANOVA). Concordantly, increasing D2HGD H expression significantly elevated the levels of α-KG in these cells (right panels, in a) and b), p=0.0068 and p<0.0001, respectively -ANOVA). All data shown represent mean and SD of three replicates/sample type. The data from panel a) are shown in Figure 1d , which depicts the relative abundance of D2-HG and α-KG. Densitometric quantification, normalized by β-actin, is show at the bottom of the western blots. Figure 7 . Differential effects of WT and mutant D2HGDH towards α-KG-dependent dioxygenases a) Histone demethylases: the methylation of H3 lysine residues was determined by western blot in HEK-293 stably expressing WT or mutant D2HGDH; whereas the WT enzyme suppressed K4, K9, K27 methylation, expression of the mutant proteins had little or no effect, and mimicked the empty MSCV control cells. Note that the H3K79me2 level is not influenced by D2HGDH, as this lysine is not regulated by the Jumonji family of α-KGdependent demethylases. Densitometric quantification, normalized by β-actin, is show at the bottom of each panel. b) HIF1α prolyl-hydroxylases: under hypoxia (1% O 2 , 16h), the levels of HIF1α hydroxylation (Pro-402) were increased and total HIF1α markedly decreased in cells expressing WT but not any of the mutant D2HGDH enzymes. c) TET enzymes: Top panel: The levels of 5hmC were quantified by intracellular FACS and found to be lower in cells expressing mutant D2HGDH than in WT cells, as shown by the left-shift of D2HGDH-mutant expressing cells in the histogram. Mid panel: The quantification of 5hmC marks was also performed using a capture and detection antibodybased approach. Abundance of 5hmC marks was measured by absorbance, and reported as relative values normalized by a positive control, a polynucleotide containing 20% 5hmC. Cells expressing empty vector (MSCV) or any of the D2HGDH mutant enzymes had significantly lower levels of 5hmC-modified DNA than the D2HGDH WT cells (p<0.001, one-way ANOVA, p<0.05, Bonferroni's multiple comparison post-test). These data represent the mean and SD of an assay performed in triplicate, confirmed in a biological replicate. Bottom panel) The quantification of 5mC was performed as above; DNA methylation was significantly higher in mutant than in WT D2HGDH cells (p<0.001, one-way ANOVA, p<0.05, Bonferroni's multiple comparison post-test). The data show represent the combined values of three biological replicates, performed in triplicate or duplicate. The western blot data shown in a) and b) were confirmed in biological replicates at least three times, and all results independently validated with a transient transfection model (Figure 1 ). Middle -quantification of IDH2 by real-time RT-PCR demonstrate a significantly higher IDH2 expression in D2HGDH-WT cells than in the empty-vector isogenic controls. (p=0.01, two-tailed Student's t-test). Rightquantification of IDH2 by real-time RT-PCR demonstrate a significantly higher IDH2 expression in HEK-293 cells exposed to synthetic α-KG than vehicle control (p<0.001, two-tailed Student's t-test). The data shown in c) (left and middle panels) represent mean and SD of three independent biological replicates (each assay performed in triplicate), displayed as relative expression (sh-ctrl vs. sh-D2HGDH, or MSCV vs. D2HGDH-WT); the data shown in the right panel is the mean -/+ SD of a representative assay performed in triplicatetwo independent biological replicates were completed and yielded similar results. In all instances, IDH2 expression was normalized to that of a housekeeping gene TBP, relative quantification achieved by calculating ΔΔCt, and expression defined as 2 -ΔΔCt , where cells expressing control vector, or vehicle, represent the baseline. 2b
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c The cell line U2932 showed a pattern of putative single copy loss across the entire D2HDGH locus and the upstream region (4 Mbp from D2HGDH's transcription start site). This finding was in agreement with an earlier report on the karyotype of this cell line (Leukemia and Lymphoma, 2002; 43: 2179 -2189 . The threshold for positive calls (copy number loss) was 0.7 or, when only one exon appeared to be targeted, 0.65. Farage WT WT 2 WT 2 WT 2 WT 2 WT 2 WT 2 WT 2 OCI-Ly8 WT WT 1-3 WT 1-3 WT 1-3 WT 1-3 Mutant 1,3 WT 2 WT 1,3,4 WT 1-3 OCI-Ly10 WT WT 1-3 WT 1-4 WT 1-4 WT 1-4 WT 1-4 WT 1,3,4 M 7 WT 1-4,7 OCI-Ly19 WT WT 2,5 WT 2,5 WT 2,5 WT 2,5 WT 2,5 WT 2,5 WT 2, 5, 7 The cell lines analyzed for the histone and DNA methylation, HIF hydroxylation and alpha-KG or D2-HG levels (Figure 7 and Supplementary Figure 12 ) are listed above.
MLPA
The remaining cell lines sequenced for D2HGDH ( Supplementary Table1 ) are listed below.
MLL2 and MLL3 encode histone methyltransferase that methylates H3K4; MLL2 and MLL3 mutations are likely loss-of-function thus leading to lower methylation of H3K4, yet cell lines mutant for both D2HGDH and MLL2 or MLL3 display high H3K4me3 levels.
The methylation of H3K4m3 was higher in OCI-Ly7, SU-DHL6 and SU-DHL8, than in SU-DHL10, OCI-Ly1, OCI-Ly4 or OCI-Ly18 and thus appear to be driven by D2HGDH WT WT c.C5636T:p.P1879L (20%)  WT  WT  WT  WT  WT  WT  4236  WT  WT  WT  WT  WT  WT  WT  WT  WT  4522  WT  WT  WT  WT  WT  WT  WT  WT  WT  5234  A426T  WT  WT  WT  WT  WT  WT  WT  WT  5485 WT c.A15176T:p.H5059L (82%) WT WT WT c.A1769T:p.Y641F (38%) c.T4197G:p.D1399E (39%) c.C4378T:p.R1460X (78%) WT 6902
A426T WT  WT  WT  WT  WT  WT  WT  WT  7518 WT c.10982delG:p.G3661fs (67%) WT WT WT c.C1907T:p.A687V (17%) WT WT WT 7572 WT WT WT WT WT WT c.4057delT:p.F1353fs (40%) WT WT Supplementary Table 9 -D2HGDH mutational status in cancer
Tumor Type Mutation -aa modification Frequency* Somatic Status References
Glioma (GBM) M153T, S178G, S197T, N443S <1% confirmed somatic TCGA (COSU329, COSU545) and Nature Genetics 2013;45(10):1141-9 Endometrioid carcinoma R107Q, V142I, A170V, R215Q, A420T 1.2% somatic or unknown TCGA (COSU419) Colon Rectal Cancer G98S, S197G # , D403N, L505M 4.7% (3/70 cases) # cell line confirmed somatic Nature 2012;488:660-4 Lung adenocarcinoma/squamous cel Q129H, S149F, G201W, K252N, T390K, G438C, A455T <1% somatic or unknown TCGA (COSU417/418); Cell 2012;150 (6) Green font -same residue was reoprted mutated in D-2-hydroxyglutaric aciduria (D2-HGA Red font -same mutation found in D2-HGA patients When it was investigated, all mutations were found to be heterozygou *To be more stringent, all SNPs -rare or frequent -were removed from this analysis, even when the variant was described in COSMIC as a somatic even
